Venture
Endeavor Biomedicines, Inc.
Latest Form D 2024-05-03- CIK 1909364
- State CA
- Biotechnology
- 2 Form D offerings since 2022-02-07
- Total sold
- $222M
- across 2 offerings
- Rounds
- 2
- Form D offerings since 2022-02-07
- Latest round
- $133M
- 2024-05-03 · 021-512326
- Investors
- 32
- on the latest round
Connected
named in its Form D filingsOfferings · since 2022-02-072 Form D offeringsExemptions506(b)People · Item 3John Hood + 9 moreInvestors · dashboardInferred investors
Endeavor Biomedicines, Inc.CIK 1909364
Round timeline
amount sold · by first filed2024-05-03 · $133M
- 2022-02-07$89.1M021-432641
- 2024-05-03$133M021-512326
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($133M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-512326 | First filed2024-05-03 | Latest2024-05-03 | Sought$133M | Sold$133M | Investors32 | Exemptions506(b) |
| 021-432641 | First filed2022-02-07 | Latest2022-02-07 | Sought$101M | Sold$89.1M | Investors16 | Exemptions506(b) |
Who backs Endeavor Biomedicines, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2024-05-03
| Name | Relationship |
|---|---|
| John Hood | RelationshipExecutive Officer, Director |
| Miguel de los Rios | RelationshipExecutive Officer |
| Enoch Kariuki | RelationshipExecutive Officer |
| Vishaal Turakhia | RelationshipExecutive Officer |
| Chris Krueger | RelationshipExecutive Officer |
| Bernard Davitian | RelationshipDirector |
| Patrick G. Enright | RelationshipDirector |
| Wing Cheong Lam | RelationshipDirector |
| Monal Mehta | RelationshipDirector |
| Karan Takhar | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- California (CA)
- Exemptions
- Rule 506(b)
- First filed
- 2022-02-07
- Latest filing
- 2024-05-03
Who backs Endeavor Biomedicines, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗